Sharing some exciting news today: Redesign Health has closed our Series C financing round led by General Catalyst, and including CVS Health Ventures, UPMC Enterprises, Declaration Partners, Eden Global Partners, EUCLIDEAN CAPITAL, LLC, Samsung Next, and TriplePoint Capital. We’re also pleased to welcome Hemant Taneja, CEO and Managing Director at General Catalyst, to our Board of Directors.

Alongside their investments, General Catalyst, CVS Health Ventures and UPMC Enterprises will leverage our platform tools, technologies, and insights to help build and support dozens of businesses addressing unmet needs in the coming years.

Learn more about how this will fuel our new innovation model that seamlessly combines the vast expertise, distribution and capital of large existing companies with the start-up DNA of entrepreneurs unconstrained by innovators’ dilemmas here: https://lnkd.in/ermmegke